(Q38021848)

27 August 2017

title

HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults (English)

1 reference

27 August 2017

main subject

anti-retroviral agent

0 references

cardiovascular disease

1 reference

1

Steven E Lipshultz

1 reference

27 August 2017

Catherine M Mas

2

1 reference

27 August 2017

Jacqueline M Henkel

3

1 reference

27 August 2017

Vivian I Franco

4

1 reference

27 August 2017

Stacy D Fisher

5

1 reference

27 August 2017

Tracie L Miller

6

1 reference

27 August 2017

publication date

1 June 2012

1 reference

Expert Review of Anti-infective Therapy

27 August 2017

published in

1 reference

27 August 2017

volume

10

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

661-674

1 reference

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

27 August 2017

cites work

1 reference

Adipose tissue as a target of HIV-1 antiretroviral drugs. Potential consequences on metabolic regulations.

21 January 2018

1 reference

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

Myocarditis in CD8-depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors

21 January 2018

1 reference

Contribution of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto Study cohort

21 January 2018

1 reference

High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

21 January 2018

1 reference

Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus

21 January 2018

1 reference

Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography

21 January 2018

1 reference

Inotropic contractile reserve can risk-stratify patients with HIV cardiomyopathy: a dobutamine stress echocardiography study.

21 January 2018

1 reference

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

21 January 2018

1 reference

Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome

21 January 2018

1 reference

Replication of HIV-1 in vivo and in vitro

21 January 2018

1 reference

Prevalence of Cardiac Diastolic Dysfunction in HIV-Infected Patients: Results of the HIV-HEART Study

21 January 2018

1 reference

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

21 January 2018

1 reference

Pericardial effusion in AIDS. Incidence and survival

21 January 2018

1 reference

Pericardial effusion of HIV-infected patients ? Results of a prospective multicenter cohort study in the era of antiretroviral therapy

21 January 2018

1 reference

21 January 2018

1 reference

Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol

21 January 2018

1 reference

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine

21 January 2018

1 reference

High rate of coronary artery abnormalities in adolescents and young adults infected with human immunodeficiency virus early in life.

21 January 2018

1 reference

Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.

21 January 2018

1 reference

Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.

21 January 2018

1 reference

Cardiac morbidity and related mortality in children with HIV infection

21 January 2018

1 reference

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared with healthy controls

21 January 2018

1 reference

Heightened inflammation is linked to carotid intima-media thickness and endothelial activation in HIV-infected children.

21 January 2018

1 reference

Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

21 January 2018

1 reference

Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

21 January 2018

1 reference

Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

21 January 2018

1 reference

HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells

21 January 2018

1 reference

Human immunodeficiency virus infection and macrophage cholesterol metabolism

21 January 2018

1 reference

Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients

21 January 2018

1 reference

Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients

21 January 2018

1 reference

Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.

21 January 2018

1 reference

Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue

21 January 2018

1 reference

In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue

21 January 2018

1 reference

Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.

21 January 2018

1 reference

Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy

21 January 2018

1 reference

Protease inhibitor-associated QT interval prolongation

21 January 2018

1 reference

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

21 January 2018

1 reference

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons

21 January 2018

1 reference

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients

21 January 2018

1 reference

Metabolic syndrome associated with HIV and highly active antiretroviral therapy

21 January 2018

1 reference

HIV and HAART-Associated Dyslipidemia

21 January 2018

1 reference

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

21 January 2018

1 reference

HIV infection and the risk of diabetes mellitus.

21 January 2018

1 reference

Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1.

21 January 2018

1 reference

Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

21 January 2018

1 reference

HIV, metabolic syndrome X, inflammation, oxidative stress, and coronary heart disease risk : role of protease inhibitor exposure.

21 January 2018

1 reference

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

21 January 2018

1 reference

Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor

21 January 2018

1 reference

Maraviroc for previously treated patients with R5 HIV-1 infection

21 January 2018

1 reference

Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome

21 January 2018

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

21 January 2018

1 reference

Advances and research directions in the prevention of mother-to-child HIV-1 transmission

21 January 2018

1 reference

Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals

21 January 2018

1 reference

Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).

21 January 2018

1 reference

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

21 January 2018

1 reference

Ventricular dysfunction clinical research in infants, children and adolescents

21 January 2018

1 reference

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

Endothelial function in HIV-infected persons.

21 January 2018

1 reference

No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial

21 January 2018

1 reference

Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort

21 January 2018

1 reference

Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis

21 January 2018

1 reference

Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction

21 January 2018

1 reference

Highly active antiretroviral therapy attenuates re-endothelialization and alters neointima formation in the rat carotid artery after balloon injury

21 January 2018

1 reference

Increasing incidence of ischemic stroke in patients with HIV infection

21 January 2018

1 reference

Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.

21 January 2018

1 reference

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

21 January 2018

1 reference

Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study.

21 January 2018

1 reference

Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.

21 January 2018

1 reference

Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium

21 January 2018

1 reference

Recent advances in antiretroviral drugs

21 January 2018

1 reference

Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease

21 January 2018

1 reference

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients

21 January 2018

1 reference

Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.12.53

1 reference

release_73aiwg3my5gb7anjwbw32qjzju

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/73aiwg3my5gb7anjwbw32qjzju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference